ImageneBio (IMA) EPS (Weighted Average and Diluted) (2021 - 2024)
Historic EPS (Weighted Average and Diluted) for ImageneBio (IMA) over the last 4 years, with Q4 2024 value amounting to $18.12.
- ImageneBio's EPS (Weighted Average and Diluted) rose 463000.0% to $18.12 in Q4 2024 from the same period last year, while for Dec 2024 it was $14.93, marking a year-over-year increase of 101595.09%. This contributed to the annual value of -$1.02 for FY2024, which is 3742.33% up from last year.
- ImageneBio's EPS (Weighted Average and Diluted) amounted to $18.12 in Q4 2024, which was up 463000.0% from -$2.58 recorded in Q3 2024.
- In the past 5 years, ImageneBio's EPS (Weighted Average and Diluted) ranged from a high of $18.12 in Q4 2024 and a low of -$2.58 during Q3 2024
- Moreover, its 4-year median value for EPS (Weighted Average and Diluted) was -$0.4 (2023), whereas its average is $0.72.
- Over the last 5 years, ImageneBio's EPS (Weighted Average and Diluted) had its largest YoY gain of 463000.0% in 2024, and its largest YoY loss of 54500.0% in 2024.
- ImageneBio's EPS (Weighted Average and Diluted) (Quarter) stood at $0.1 in 2021, then tumbled by 490.19% to -$0.39 in 2022, then decreased by 2.56% to -$0.4 in 2023, then surged by 4630.0% to $18.12 in 2024.
- Its EPS (Weighted Average and Diluted) stands at $18.12 for Q4 2024, versus -$2.58 for Q3 2024 and -$0.28 for Q2 2024.